Document is current
Any future updates will be listed below
-
Authors
Tran, Thinh N. https://orcid.org/0000-0002-3428-2507
Fong, Chris
Pichotta, Karl
Luthra, Anisha
Shen, Ronglai https://orcid.org/0000-0001-9694-584X
Chen, Yuan https://orcid.org/0000-0002-8734-007X
Waters, Michele https://orcid.org/0000-0002-5416-5172
Kim, Susie
Li, Xiang https://orcid.org/0000-0003-2782-2250
de Bruijn, Ino https://orcid.org/0000-0001-5427-4750
Riely, Gregory
Berger, Michael F. https://orcid.org/0000-0003-3882-5000
Ladanyi, Marc https://orcid.org/0000-0001-9055-7213
Chakravarty, Debyani https://orcid.org/0000-0001-8629-5732
Schultz, Nikolaus https://orcid.org/0000-0002-0131-4904
Jee, Justin https://orcid.org/0000-0001-9783-0139
-
Funding
Funding for this research was provided by:
Memorial Sloan-Kettering Cancer Center (P30 CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (K08 CA286842)
- License Information
-
More Information
Article History
Received: 8 July 2024
Accepted: 19 August 2025
First Online: 26 September 2025
Competing interests
: The authors declare the following competing interests: G.R. declares professional services and activities (uncompensated) for the American Association for Cancer Research, the American Society of Clinical Oncology, Mirati Therapeutics, Pfizer, Takeda Pharmaceuticals and Verastem; and professional services and activities for Harborside Press, MJH Associates, the National Comprehensive Cancer Network, Phillips Gilmore Oncology Communications, Research to Practice and Triptych Health Partners. N.S. declares professional services and activities (uncompensated) for Cambridge Innovation Institute and Innovation in Cancer Informatics; and professional services and activities for Novartis and OneOncology. M.L. declares equity in and professional services and activities (uncompensated) for Paige.AI. M.F.B. declares professional services and activities for AstraZeneca and Paige.AI; professional services and activities (uncompensated) for JCO Precision Oncology and the Journal of Molecular Diagnostics; and intellectual property rights in SOPHiA GENETICS. J.J. has a patent licensed by MDSeq. T.N.T., C.F., K.P., A.L., M.W., S.K., X.L., I.B., R.S., Y.C., and D.C. declare no competing financial and non-financial interests.
